News

Researchers found that the nanoparticle alleviates symptoms of inflammatory bowel disease more effectively than common FDA-approved medications.

Congratulations to Sunitha Nagrath on being in the inaugural class of Rogel Scholars!

Members of six BI groups were awarded NSF Graduate Fellowships.

The inaugural 2019 BI Innovator Awards are awarded to Tim Bruns, Yichun Wang and Rose Cersonsky.

Through the Michigan Investment in New Technology Startups (MINTS) initiative, UM will invest $500K in GreenMark Medical, a startup based on technologies developed by BI Director, Joerg Lahann.

A new publication from Steve Schwendeman and his collaborators from Georgia Tech appears in Nature Biomedical Engineering and features micro-needle patches for long-acting contraceptive delivery.

Crain’s Detroit features Evoq Therapeutics, a startup company co-founded by James Moon and Anna Schwendeman.

An article from the Lahann lab was recently published in Science. The article is entitled “Templated nanofiber synthesis via chemical vapor polymerization into liquid crystalline films” and reports on nanofiber arrays that can lead to various functional coatings.

Sunitha Nagrath is the recipient of the 2018 Analytical Chemistry Young Innovator Award. The award honors the contributions of an individual who has demonstrated exceptional technical advancement and innovation in the field of microfluidics or nanofluidics in his or her early career.

The article entitled “Profiling Heterogeneous Circulating Tumor Cells (CTC) Populations in Pancreatic Cancer Using a Serial Microfluidic CTC Carpet Chip” appears in Advanced Biosystems.

This award recognizes scientists and pharmaceutical professionals who are early in their careers, who have made a significant impact in the pharmaceutical sciences that promotes public health.

Cindy Chestek (Biomedical Engineering), James Moon (Pharmaceutical Sciences) and A. Schwendeman (Pharmaceutical Sciences) were promoted to Associate Professor with tenure. Congratulations!

Peter Tessier was elected a Fellow of the American Institute for Medical and Biological Engineering (AIMBE).  AIMBE comprises of leaders in medical and biological engineering, consisting of academic, industrial, professional society councils and elected fellows.

Carlos Aguilar is one of the recipients of the 2018 3M Non-Tenured Faculty Awards.  Awarded by 3M Corporation, this award recognizes junior faculty who demonstrate outstanding research, experience, teaching and academic leadership.

The article entitled “Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™” appeared in MAb.